Full CoverageUS pharma bets big on China to snap up potential blockbuster drugs
By Sriparna Roy
Top news
China’s Biotech Moment Ignites a 60% Stock Rally That Beats AI
By Sangmi Cha, Winnie Hsu & Amber Tong
China is catching up to the U.S. in pharmaceuticals, but it’s not too late to turn that around
By Paul Verdin
Cover Story: Chinese Biotech Is Having a ‘DeepSeek Moment’
By Han Wei
All coverage
While the US might have enough capital, the R&D innovation boom in China could lead to a stagnation in the states
By Lisa Henderson
U.S. biotechs, pharmas can learn from China to accelerate drug development
By Jonathan Block, MPH
Chinese biotech stocks have pulled ahead of the country’s buzzing tech sector
By Theodora Lee Joseph
Pharma sees expanding deals with Chinese companies (MRK:NYSE)
By Jonathan Block, MPH